ELMD
Electromed, Inc.
Company overview
- Market capitalization
- $235.67M
- Employees
- 177
- Latest publication
- 2026-09-29
About Electromed, Inc.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Financial statements
Income Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 19,417,000USD | 18,575,000USD | 18,897,000USD | 16,887,000USD | 17,393,000USD | 15,684,000USD | 16,254,999USD | 14,668,000USD |
| Gross Profit | 15,284,000USD | 14,643,000USD | 14,819,000USD | 13,197,000USD | 13,624,000USD | 12,229,000USD | 12,627,000USD | 11,491,000USD |
| Research Development | 328,000USD | 361,000USD | 384,000USD | 241,000USD | 302,000USD | 277,000USD | 251,000USD | 166,000USD |
| Selling General Administrative | 11,131,000USD | 10,516,000USD | 10,372,000USD | 10,286,000USD | 10,282,000USD | 9,812,000USD | 9,479,000USD | 9,387,000USD |
| Total Operating Expenses | 11,459,000USD | 10,877,000USD | 11,199,000USD | 10,527,000USD | 10,372,000USD | 10,089,000USD | 10,085,000USD | 9,553,000USD |
| Operating Income | 3,825,000USD | 3,766,000USD | 3,620,000USD | 2,670,000USD | 3,252,000USD | 2,140,000USD | 2,542,000USD | 1,938,000USD |
| Income Before Tax | 3,961,000USD | 3,866,000USD | 3,729,000USD | 2,804,000USD | 3,175,000USD | 2,282,000USD | 2,694,000USD | 2,133,000USD |
| Income Tax Expense | 560,000USD | 863,000USD | 968,000USD | 668,000USD | 971,000USD | 391,000USD | 726,000USD | 659,000USD |
| Net Income | 3,961,000USD | 3,003,000USD | 2,761,000USD | 2,136,000USD | 2,204,000USD | 1,891,000USD | 1,968,000USD | 1,474,000USD |
| Cost Of Revenue | — | 3,932,000USD | 4,078,000USD | 3,690,000USD | 3,769,000USD | 3,455,000USD | 3,628,000USD | 3,177,000USD |
| Interest Income | — | 100,000USD | 109,000USD | 134,000USD | 135,000USD | 142,000USD | 152,000USD | 195,000USD |
| Net Interest Income | — | 100,000USD | 109,000USD | 134,000USD | 135,000USD | 142,000USD | 152,000USD | 195,000USD |
| Tax Provision | — | 863,000USD | 968,000USD | 668,000USD | 971,000USD | 391,000USD | 726,000USD | 659,000USD |
| Net Income From Continuing Ops | — | 3,003,000USD | 2,761,000USD | 2,136,000USD | 2,204,000USD | 1,891,000USD | 1,968,000USD | 1,474,000USD |
| Ebit | — | 3,766,000USD | 3,620,000USD | 2,670,000USD | 3,252,000USD | 2,140,000USD | 2,542,000USD | 1,938,000USD |
| Ebitda | — | 4,053,000USD | 3,878,000USD | 2,929,000USD | 3,649,000USD | 2,423,000USD | 2,814,000USD | 2,158,000USD |
| Depreciation And Amortization | — | 287,000USD | 258,000USD | 259,000USD | 397,000USD | 283,000USD | 272,000USD | 220,000USD |
| Reconciled Depreciation | — | 287,000USD | 258,000USD | 259,000USD | 397,000USD | 283,000USD | 272,000USD | 220,000USD |
| Total Other Income Expense Net | — | 100,000USD | 109,000USD | 134,000USD | -77,000USD | 142,000USD | 152,000USD | 195,000USD |
| Selling And Marketing Expenses | — | — | 443,000USD | — | — | — | 355,000USD | — |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 73,776,000USD | 64,000,000USD | 54,716,000USD | 48,067,000USD | 41,659,000USD | 35,756,000USD | 32,471,000USD | 31,299,750USD |
| Cost Of Revenue | 15,833,000USD | 14,029,000USD | 12,990,000USD | 11,548,000USD | 10,217,000USD | 8,451,000USD | 7,271,000USD | 7,451,806USD |
| Gross Profit | 57,943,000USD | 49,971,000USD | 41,726,000USD | 36,519,000USD | 31,442,000USD | 27,305,000USD | 25,200,000USD | 23,847,944USD |
| Research Development | 1,314,000USD | 996,000USD | 656,000USD | 916,000USD | 1,356,000USD | 1,722,000USD | 1,050,000USD | 583,311USD |
| Selling General Administrative | 42,748,000USD | 39,315,000USD | 33,002,000USD | 30,560,000USD | 27,114,000USD | 22,443,000USD | 19,944,851USD | 20,446,122USD |
| Selling And Marketing Expenses | 1,680,000USD | — | 1,487,000USD | 1,034,999USD | — | — | — | — |
| Total Operating Expenses | 44,062,000USD | 40,099,000USD | 35,145,000USD | 32,511,000USD | 28,470,000USD | 24,165,000USD | 20,082,000USD | 21,018,321USD |
| Operating Income | 13,881,000USD | 9,872,000USD | 6,581,000USD | 4,008,000USD | 2,972,000USD | 3,140,000USD | 5,118,000USD | 2,829,623USD |
| Total Other Income Expense Net | 479,000USD | 412,000USD | 455,000USD | 78,000USD | 25,000USD | 27,000USD | 121,000USD | 90,707USD |
| Income Before Tax | 14,360,000USD | 10,284,000USD | 7,036,000USD | 4,086,000USD | 2,997,000USD | 3,167,000USD | 5,239,000USD | 2,920,330USD |
| Income Tax Expense | 3,059,000USD | 2,747,000USD | 1,886,000USD | 920,000USD | 692,000USD | 805,000USD | 1,078,000USD | 940,000USD |
| Net Income | 11,301,000USD | 7,537,000USD | 5,150,000USD | 3,166,000USD | 2,305,000USD | 2,362,000USD | 4,161,000USD | 1,980,330USD |
| Interest Income | — | 624,000USD | 455,000USD | 78,000USD | 25,000USD | 27,000USD | — | 90,710USD |
| Net Interest Income | — | 624,000USD | 455,000USD | 78,000USD | 25,000USD | 39,000USD | 120,748USD | 90,707USD |
| Tax Provision | — | 2,747,000USD | 1,886,000USD | 920,000USD | 692,000USD | 805,000USD | 1,078,000USD | 940,000USD |
| Net Income From Continuing Ops | — | 7,537,000USD | 5,150,000USD | 3,166,000USD | 2,305,000USD | 2,362,000USD | 4,161,438USD | 1,969,218USD |
| Ebit | — | 9,872,000USD | 6,581,000USD | 4,008,000USD | 2,972,000USD | 3,140,000USD | 5,118,000USD | 2,829,623USD |
| Ebitda | — | 11,044,000USD | 7,422,000USD | 4,621,000USD | 3,600,000USD | 3,750,000USD | 5,859,000USD | 3,754,850USD |
| Depreciation And Amortization | — | 1,172,000USD | 841,000USD | 613,000USD | 628,000USD | 610,000USD | 741,000USD | 925,227USD |
| Reconciled Depreciation | — | 1,172,000USD | 841,000USD | 613,000USD | 628,000USD | 610,000USD | 738,230USD | 925,227USD |
| Interest Expense | — | — | — | 78,000USD | 25,000USD | 27,000USD | 120,748USD | 90,707USD |
| Net Income Applicable To Common Shares | — | — | — | 3,166,000USD | 2,305,000USD | 2,362,000USD | 4,161,439USD | 1,969,218USD |
| Non Operating Income Net Other | — | — | — | — | — | -12,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q4 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 66,267,000USD | 59,474,000USD | 54,910,000USD | 53,614,000USD | 53,802,000USD | 52,451,000USD | 52,274,000USD | 48,915,000USD |
| Cash And Equivalents | 20,450,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 57,368,000USD | 50,228,000USD | 45,567,000USD | 44,559,000USD | 45,082,000USD | 44,195,000USD | 44,189,000USD | 41,010,000USD |
| Other Current Assets | 1,170,000USD | 1,697,000USD | 906,000USD | 543,000USD | 800,000USD | 492,000USD | 1,101,000USD | 592,000USD |
| Other Non Current Assets | 1,270,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 12,288,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 12,222,000USD | 10,226,000USD | 9,375,000USD | 8,759,000USD | 10,468,000USD | 8,511,000USD | 8,667,000USD | 7,419,000USD |
| Other Non Current Liabilities | 66,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 53,979,000USD | 49,167,000USD | 45,439,000USD | 44,745,000USD | 43,209,000USD | 43,940,000USD | 43,603,000USD | 41,488,000USD |
| Total Equity Including Noncontrolling Interest | 53,979,000USD | — | — | — | — | — | — | — |
| Net Receivables | 29,805,000USD | 28,251,000USD | 27,412,000USD | 26,132,000USD | 25,696,000USD | 25,498,000USD | 23,772,000USD | 23,120,000USD |
| Inventory | 3,681,000USD | 3,295,000USD | 3,458,000USD | 3,771,000USD | 3,299,000USD | 2,968,000USD | 3,081,000USD | 3,434,000USD |
| Property Plant Equipment Net | 5,345,000USD | 5,209,000USD | 5,379,000USD | 5,158,000USD | 4,912,000USD | 5,516,000USD | 5,324,000USD | 5,003,000USD |
| Accounts Payable | 2,643,000USD | 2,595,000USD | 2,320,000USD | 3,138,000USD | 2,667,000USD | 1,879,000USD | 1,506,000USD | 1,784,000USD |
| Common Stock | 84,000USD | 83,000USD | 83,000USD | 84,000USD | 83,000USD | 85,000USD | 86,000USD | 85,000USD |
| Retained Earnings | 28,564,000USD | 25,135,000USD | 22,283,000USD | 22,308,000USD | 21,185,000USD | 22,555,000USD | 22,577,000USD | 20,587,000USD |
| Intangible Assets | — | 354,000USD | 1,482,000USD | 1,415,000USD | 1,323,000USD | 588,000USD | 609,000USD | 660,000USD |
| Total Liab | — | 10,307,000USD | 9,471,000USD | 8,869,000USD | 10,593,000USD | 8,511,000USD | 8,671,000USD | 7,427,000USD |
| Other Current Liab | — | 7,631,000USD | 6,673,000USD | 5,621,000USD | 7,728,000USD | 6,632,000USD | 7,057,000USD | 5,447,000USD |
| Capital Stock | — | 83,000USD | 83,000USD | 84,000USD | 83,000USD | 85,000USD | 86,000USD | 85,000USD |
| Cash | — | 16,985,000USD | 13,791,000USD | 14,113,000USD | 15,287,000USD | 15,237,000USD | 16,235,000USD | 13,864,000USD |
| Cash And Short Term Investments | — | 16,985,000USD | 13,791,000USD | 14,113,000USD | 15,287,000USD | 15,237,000USD | 16,235,000USD | 13,864,000USD |
| Net Debt | — | -16,985,000USD | -13,791,000USD | -14,113,000USD | -15,089,000USD | -15,237,000USD | -16,127,000USD | -13,864,000USD |
| Property Plant Equipment Gross | — | 5,355,000USD | 5,379,000USD | 5,158,000USD | 10,916,000USD | 5,516,000USD | — | — |
| Common Stock Shares Outstanding | — | 8,647,794shares | 8,689,290shares | 8,681,703shares | 8,718,900shares | 8,967,838shares | 8,953,349shares | 8,980,714shares |
| Non Current Assets Total | — | 9,246,000USD | 9,343,000USD | 9,055,000USD | 8,720,000USD | 8,256,000USD | 8,085,000USD | 7,905,000USD |
| Non Current Liabilities Total | — | 81,000USD | 96,000USD | 110,000USD | 125,000USD | 0USD | 4,000USD | 8,000USD |
| Non Current Liabilities Other | — | 81,000USD | 96,000USD | 110,000USD | 125,000USD | — | 4,000USD | 8,000USD |
| Non Currrent Assets Other | — | 1,221,000USD | 20,000USD | 20,000USD | 2,485,000USD | 703,000USD | 2,152,000USD | 90,000USD |
| Net Working Capital | — | 40,002,000USD | 36,192,000USD | 35,800,000USD | 34,614,000USD | 35,684,000USD | 35,522,000USD | 33,591,000USD |
| Unclassified Non Current Assets | — | 2,462,000USD | 2,462,000USD | 2,462,000USD | — | 1,449,000USD | — | 2,152,000USD |
| Unclassified Equity | — | 23,866,000USD | 22,990,000USD | 22,269,000USD | 21,858,000USD | 21,215,000USD | 20,854,000USD | 20,731,000USD |
| Short Long Term Debt Total | — | — | 96,000USD | 110,000USD | 198,000USD | — | 108,000USD | 8,000USD |
| Accumulated Other Comprehensive Income | — | — | — | 0USD | 0USD | — | — | — |
| Short Term Debt | — | — | — | — | 73,000USD | — | 104,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 66,267,000USD | 53,802,000USD | 52,234,000USD | 45,806,000USD | 41,364,000USD | 37,109,000USD | 33,244,999USD | 29,354,188USD |
| Cash And Equivalents | 20,450,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 57,368,000USD | 45,082,000USD | 44,173,000USD | 37,787,000USD | 34,539,000USD | 31,704,000USD | 28,023,000USD | 24,539,031USD |
| Other Current Assets | 1,170,000USD | 800,000USD | 329,001USD | 1,577,000USD | 1,870,000USD | 276,000USD | 615,000USD | 353,214USD |
| Other Non Current Assets | 1,270,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 12,288,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 12,222,000USD | 10,468,000USD | 7,677,000USD | 8,053,000USD | 7,150,000USD | 4,639,000USD | 2,986,000USD | 3,620,202USD |
| Other Non Current Liabilities | 66,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 53,979,000USD | 43,209,000USD | 44,545,000USD | 37,667,000USD | 34,173,000USD | 32,416,000USD | 30,250,000USD | 25,733,986USD |
| Total Equity Including Noncontrolling Interest | 53,979,000USD | — | — | — | — | — | — | — |
| Net Receivables | 29,805,000USD | 25,696,000USD | 24,052,000USD | 24,617,000USD | 21,338,000USD | 17,425,000USD | 13,844,000USD | 13,755,889USD |
| Inventory | 3,681,000USD | 3,299,000USD | 3,712,000USD | 4,221,000USD | 3,178,000USD | 2,114,000USD | 3,085,000USD | 2,622,000USD |
| Property Plant Equipment Net | 5,345,000USD | 4,912,000USD | 5,252,000USD | 5,672,000USD | 4,688,000USD | 3,693,000USD | 3,869,000USD | 3,604,744USD |
| Accounts Payable | 2,643,000USD | 2,667,000USD | 1,010,000USD | 1,372,000USD | 1,261,000USD | 685,000USD | 556,000USD | 586,575USD |
| Common Stock | 84,000USD | 83,000USD | 87,000USD | 86,000USD | 85,000USD | 85,000USD | 86,000USD | 84,084USD |
| Retained Earnings | 28,564,000USD | 21,185,000USD | 23,668,000USD | 18,793,000USD | 15,780,000USD | 14,922,000USD | 13,684,000USD | 9,522,076USD |
| Intangible Assets | — | 1,323,000USD | 657,000USD | 605,000USD | 599,000USD | 663,000USD | 598,000USD | 581,413USD |
| Total Liab | — | 10,593,000USD | 7,689,000USD | 8,139,000USD | 7,191,000USD | 4,693,000USD | 2,994,999USD | 3,620,202USD |
| Other Current Liab | — | 7,728,000USD | 6,592,000USD | 6,345,000USD | 4,300,000USD | 3,633,000USD | 2,358,000USD | 2,775,435USD |
| Capital Stock | — | 83,000USD | 87,000USD | 86,000USD | 85,000USD | 85,000USD | 85,678USD | 84,084USD |
| Cash | — | 15,287,000USD | 16,079,999USD | 7,372,000USD | 8,153,000USD | 11,889,000USD | 10,479,000USD | 7,807,928USD |
| Cash And Short Term Investments | — | 15,287,000USD | 16,079,999USD | 7,372,000USD | 8,153,000USD | 11,889,000USD | 10,479,000USD | 7,807,928USD |
| Net Debt | — | -15,089,000USD | -15,992,999USD | -7,211,000USD | -8,112,000USD | -11,802,000USD | -10,398,000USD | -7,762,871USD |
| Short Term Debt | — | 73,000USD | 75,000USD | 80,000USD | — | 33,000USD | 72,000USD | 30,320USD |
| Short Long Term Debt Total | — | 198,000USD | 87,000USD | 161,000USD | 41,000USD | 87,000USD | 81,000USD | 45,057USD |
| Property Plant Equipment Gross | — | 10,916,000USD | 10,422,000USD | 5,672,000USD | 4,688,000USD | 3,605,000USD | 3,788,469USD | 3,604,744USD |
| Accumulated Other Comprehensive Income | — | 0USD | — | 0USD | 0USD | 0USD | 0USD | -3,928,000USD |
| Common Stock Shares Outstanding | — | 8,718,900shares | 8,864,585shares | 8,700,833shares | 8,768,703shares | 8,911,842shares | 8,826,418shares | 8,631,469shares |
| Non Current Assets Total | — | 8,720,000USD | 8,061,000USD | 8,019,000USD | 6,825,000USD | 5,405,000USD | 5,221,999USD | 4,815,157USD |
| Non Current Liabilities Total | — | 125,000USD | 12,000USD | 86,000USD | 41,000USD | 54,000USD | 8,999USD | 14,737USD |
| Non Current Liabilities Other | — | 125,000USD | 12,000USD | 86,000USD | 41,000USD | 54,000USD | 8,868USD | — |
| Non Currrent Assets Other | — | 2,485,000USD | 2,152,000USD | 161,000USD | 120,000,000USD | 88,000USD | 754,999USD | 44USD |
| Net Working Capital | — | 34,614,000USD | 36,496,000USD | 29,734,000USD | 27,389,000USD | 27,065,000USD | 25,036,159USD | 20,918,829USD |
| Unclassified Equity | — | 21,858,000USD | 20,703,000USD | 18,702,000USD | 18,223,000USD | 17,324,000USD | 16,394,322USD | 19,971,742USD |
| Other Assets | — | — | 1USD | 1,581,000USD | 1,538,000USD | 1,137,000USD | 755,000USD | 629,000USD |
| Current Deferred Revenue | — | — | 277,000USD | -80,000USD | 1,538,000USD | -33,000USD | -72,328USD | -30,320USD |
| Net Tangible Assets | — | — | — | 37,062,000USD | 33,574,000USD | 31,753,000USD | 29,650,926USD | 25,152,573USD |
| Unclassified Non Current Assets | — | — | — | — | -120,000,000USD | — | -1,353,389USD | — |
| Other Liab | — | — | — | — | — | — | 8,868USD | — |
| Good Will | — | — | — | — | — | — | 598,389USD | 581,413USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20262026-06-30 · USD | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD | FY 20212021-06-30 · USD | FY 20202020-06-30 · USD | FY 20192019-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 926,000USD | 1,172,000USD | 841,000USD | 613,000USD | 628,000USD | 610,000USD | 741,000USD | 925,227USD |
| Stock Based Compensation | 2,722,000USD | 3,059,000USD | 1,692,000USD | 708,000USD | 976,000USD | 1,024,000USD | 902,000USD | 924,071USD |
| Deferred Income Tax | 426,000USD | — | — | — | — | — | — | — |
| Change To Account Receivables | -5,145,000USD | -1,644,000USD | 565,000USD | -3,279,000USD | -3,913,000USD | -3,581,000USD | -350,000USD | -948,734USD |
| Change To Inventory | -517,000USD | 175,000USD | 459,000USD | -1,033,000USD | -1,072,000USD | 971,000USD | -449,000USD | -106,174USD |
| Change To Liabilities | 652,000USD | — | — | 705,000USD | 1,933,000USD | 1,284,000USD | -761,100USD | -111,443USD |
| Change In Working Capital | -5,042,000USD | -277,000USD | 1,955,000USD | -3,129,000USD | -4,106,000USD | -625,000USD | -1,482,000USD | -981,626USD |
| Operating Cash Flow | 9,665,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -1,252,000USD | -306,000USD | -395,000USD | -1,716,000USD | -1,525,000USD | -448,000USD | -977,000USD | -1,388,388USD |
| Unclassified Investing Cash Flow | -48,000USD | — | — | 1,784,000USD | 1,625,000USD | — | 1,110,196USD | 1,444,428USD |
| Investing Cash Flow | -1,300,000USD | — | — | — | — | — | — | — |
| Net Common Stock Issuance | -4,167,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 965,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | -3,202,000USD | — | — | — | — | — | — | — |
| Change In Cash | 5,163,000USD | -793,000USD | 8,708,000USD | -781,000USD | -3,736,000USD | 1,410,000USD | 2,671,000USD | 352,084USD |
| End Cash Flow | 20,450,000USD | — | — | — | — | — | — | — |
| Net Income | — | 7,537,000USD | 5,150,000USD | 3,166,000USD | 2,305,000USD | 2,362,000USD | 4,161,000USD | 1,969,218USD |
| Other Non Cash Items | — | 212,000USD | 3,556,000USD | 5,826,000USD | 4,779,000USD | 3,308,000USD | 2,554USD | 17,984USD |
| Total Cash From Operating Activities | — | 11,393,000USD | 9,067,000USD | 1,315,000USD | -686,000USD | 3,077,000USD | 4,196,000USD | 2,589,874USD |
| Free Cash Flow | — | 11,087,000USD | 8,672,000USD | -401,000USD | -2,211,000USD | 2,629,000USD | 3,219,000USD | 1,201,486USD |
| Investments | — | -306,000USD | -395,000USD | -1,716,000USD | -1,525,000USD | -448,000USD | -977,196USD | -1,386,638USD |
| Total Cashflows From Investing Activities | — | -306,000USD | -395,000USD | -1,716,000USD | -1,525,000USD | -448,000USD | -977,000USD | -1,386,638USD |
| Total Cash From Financing Activities | — | -11,880,000USD | 36,000USD | -380,000USD | -1,525,000USD | -1,219,000USD | -548,000USD | -851,152USD |
| Sale Purchase Of Stock | — | -10,000,000USD | -275,000USD | -153,000USD | -1,448,000USD | -1,124,000USD | -628,000USD | 251,849USD |
| Begin Period Cash Flow | — | 16,080,000USD | 7,372,000USD | 8,153,000USD | 11,889,000USD | 10,479,000USD | 7,808,000USD | 7,455,844USD |
| End Period Cash Flow | — | 15,287,000USD | 16,080,000USD | 7,372,000USD | 8,153,000USD | 11,889,000USD | 10,479,000USD | 7,807,928USD |
| Other Cashflows From Financing Activities | — | -1,880,000USD | 311,000USD | -227,000USD | -77,000USD | -95,000USD | -548,000USD | 251,849USD |
| Unclassified Operating Cash Flow | — | — | -4,127,000USD | -5,869,000USD | -5,268,000USD | -3,602,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -781,000USD | -3,736,000USD | 1,410,000USD | 2,671,222USD | 352,084USD |
| Other Cashflows From Investing Activities | — | — | — | -68,000USD | -100,000USD | -161,000USD | -133,000USD | -56,040USD |
| Net Borrowings | — | — | — | — | — | — | — | -1,103,001USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 3,003,000USD | 2,761,000USD | 2,136,000USD | 2,204,000USD | 1,891,000USD | 1,968,000USD | 1,474,000USD | 1,828,000USD |
| Depreciation | 287,000USD | 168,000USD | 259,000USD | 397,000USD | 283,000USD | 272,000USD | 220,000USD | 210,000USD |
| Stock Based Compensation | 846,000USD | 656,000USD | 458,000USD | 650,000USD | 757,000USD | 955,000USD | 697,000USD | 442,000USD |
| Other Non Cash Items | 846,000USD | 90,000USD | — | 212,000USD | -857,000USD | 955,000USD | 697,000USD | 138,000USD |
| Change To Account Receivables | -1,925,000USD | -1,486,000USD | -230,000USD | 79,000USD | -794,000USD | -652,000USD | 932,000USD | 1,124,000USD |
| Change To Inventory | 137,000USD | 255,000USD | -515,000USD | -389,000USD | 64,000USD | 222,000USD | 278,000USD | 381,000USD |
| Change In Working Capital | -660,000USD | -649,000USD | -2,684,000USD | 706,000USD | -857,000USD | -44,000USD | -82,000USD | 2,619,000USD |
| Total Cash From Operating Activities | 3,476,000USD | 3,026,000USD | 169,000USD | 3,859,000USD | 2,074,000USD | 3,151,000USD | 2,309,000USD | 4,489,000USD |
| Capital Expenditures | -147,000USD | -267,000USD | -267,000USD | -157,000USD | -237,000USD | -233,000USD | -37,000USD | -46,000USD |
| Free Cash Flow | 3,329,000USD | 3,293,000USD | -98,000USD | 3,702,000USD | 2,311,000USD | 2,918,000USD | 2,272,000USD | 4,443,000USD |
| Total Cashflows From Investing Activities | -154,000USD | -656,000USD | -267,000USD | -157,000USD | 146,000USD | -237,000USD | -58,000USD | -46,000USD |
| Total Cash From Financing Activities | -128,000USD | -2,692,000USD | -1,076,000USD | -3,652,000USD | -3,218,000USD | -543,000USD | -4,467,000USD | -75,000USD |
| Sale Purchase Of Stock | -152,000USD | -2,763,000USD | -1,003,000USD | -3,669,000USD | -1,795,000USD | 0USD | -4,536,000USD | -275,000USD |
| Change In Cash | 3,194,000USD | -322,000USD | -1,174,000USD | 50,000USD | -998,000USD | 2,371,000USD | -2,215,999USD | 4,368,000USD |
| Begin Period Cash Flow | 13,791,000USD | 14,113,000USD | 15,287,000USD | 15,237,000USD | 16,235,000USD | 13,864,000USD | 16,079,999USD | 11,712,000USD |
| End Period Cash Flow | 16,985,000USD | 13,791,000USD | 14,113,000USD | 15,287,000USD | 15,237,000USD | 16,235,000USD | 13,864,000USD | 16,080,000USD |
| Other Cashflows From Investing Activities | -154,000USD | -923,000USD | — | — | 146,000USD | -237,000USD | -58,000USD | — |
| Other Cashflows From Financing Activities | -12,000USD | -5,000USD | -73,000USD | 17,000USD | -1,458,000USD | -805,000USD | -15,000USD | 200,000USD |
| Investments | — | — | -267,000USD | -157,000USD | 146,000USD | -237,000USD | -58,000USD | -46,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2025Quarterly · 2024-12-31 | Product | Homecare | 14,593,000 | USD | 0000897101-25-000089 |
| Q2 2025Quarterly · 2024-12-31 | Product | Homecare Distributor | 807,000 | USD | 0000897101-25-000089 |
| Q2 2025Quarterly · 2024-12-31 | Product | Hospital | 723,000 | USD | 0000897101-25-000089 |
| Q2 2025Quarterly · 2024-12-31 | Product | Other | 132,000 | USD | 0000897101-25-000089 |
| Q1 2025Quarterly · 2024-09-30 | Product | Home Care | 13,211,000 | USD | 0000897101-24-000563 |
| Q1 2025Quarterly · 2024-09-30 | Product | Home Care Distributor | 587,000 | USD | 0000897101-24-000563 |
| Q1 2025Quarterly · 2024-09-30 | Product | Hospital | 690,000 | USD | 0000897101-24-000563 |
| Q1 2025Quarterly · 2024-09-30 | Product | Other | 180,000 | USD | 0000897101-24-000563 |
| Q4 2024Quarterly · 2024-06-30 | Product | Home Care | 13,395,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Home Care Distributor | 475,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Hospital | 626,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-06-30 | Product | Other | 336,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-06-30 | Product | Home Care | 49,503,000 | USD | 0000897101-24-000422 |
| FY 2024Yearly · 2024-06-30 | Product | Home Care Distributor | 1,852,000 | USD | 0000897101-24-000422 |
| FY 2024Yearly · 2024-06-30 | Product | Hospital | 2,535,000 | USD | 0000897101-24-000422 |
| FY 2024Yearly · 2024-06-30 | Product | Other | 826,000 | USD | 0000897101-24-000422 |
| Q3 2024Quarterly · 2024-03-31 | Product | Home Care | 12,287,000 | USD | 0000897101-24-000163 |
| Q3 2024Quarterly · 2024-03-31 | Product | Home Care Distributor | 524,000 | USD | 0000897101-24-000163 |
| Q3 2024Quarterly · 2024-03-31 | Product | Hospital | 783,000 | USD | 0000897101-24-000163 |
| Q3 2024Quarterly · 2024-03-31 | Product | Other | 277,000 | USD | 0000897101-24-000163 |
| Q2 2024Quarterly · 2023-12-31 | Product | Homecare | 12,668,000 | USD | 0000897101-25-000089 |
| Q2 2024Quarterly · 2023-12-31 | Product | Homecare Distributor | 280,000 | USD | 0000897101-25-000089 |
| Q2 2024Quarterly · 2023-12-31 | Product | Hospital | 619,000 | USD | 0000897101-25-000089 |
| Q2 2024Quarterly · 2023-12-31 | Product | Other | 122,000 | USD | 0000897101-25-000089 |
| Q1 2024Quarterly · 2023-09-30 | Product | Home Care | 11,153,000 | USD | 0000897101-24-000563 |
| Q1 2024Quarterly · 2023-09-30 | Product | Home Care Distributor | 573,000 | USD | 0000897101-24-000563 |
| Q1 2024Quarterly · 2023-09-30 | Product | Hospital | 507,000 | USD | 0000897101-24-000563 |
| Q1 2024Quarterly · 2023-09-30 | Product | Other | 91,000 | USD | 0000897101-24-000563 |
| Q4 2023Quarterly · 2023-06-30 | Product | Home Care | 12,610,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-06-30 | Product | Home Care Distributor | 227,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-06-30 | Product | Hospital | 660,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-06-30 | Product | Other | 115,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-06-30 | Product | Home Care | 43,945,000 | USD | 0000897101-24-000422 |
| FY 2023Yearly · 2023-06-30 | Product | Home Care Distributor | 1,618,000 | USD | 0000897101-24-000422 |
| FY 2023Yearly · 2023-06-30 | Product | Hospital | 2,080,000 | USD | 0000897101-24-000422 |
| FY 2023Yearly · 2023-06-30 | Product | Other | 424,000 | USD | 0000897101-24-000422 |
| Q3 2023Quarterly · 2023-03-31 | Product | Home Care | 10,971,000 | USD | 0000897101-24-000163 |
| Q3 2023Quarterly · 2023-03-31 | Product | Home Care Distributor | 501,000 | USD | 0000897101-24-000163 |
| Q3 2023Quarterly · 2023-03-31 | Product | Hospital | 440,000 | USD | 0000897101-24-000163 |
| Q3 2023Quarterly · 2023-03-31 | Product | Other | 156,000 | USD | 0000897101-24-000163 |
| FY 2022Yearly · 2022-06-30 | Product | Home Care | 38,004,000 | USD | 0000897101-23-000380 |
| FY 2022Yearly · 2022-06-30 | Product | Home Care Distributor | 1,474,000 | USD | 0000897101-23-000380 |
| FY 2022Yearly · 2022-06-30 | Product | Institutional | 1,660,000 | USD | 0000897101-23-000380 |
| FY 2022Yearly · 2022-06-30 | Product | International One | 521,000 | USD | 0000897101-23-000380 |
| FY 2021Yearly · 2021-06-30 | Product | Home Care | 32,986,000 | USD | 0000897101-22-000805 |
| FY 2021Yearly · 2021-06-30 | Product | Home Care Distributor | 563,000 | USD | 0000897101-22-000805 |
| FY 2021Yearly · 2021-06-30 | Product | Institutional | 1,549,000 | USD | 0000897101-22-000805 |
| FY 2021Yearly · 2021-06-30 | Product | International1 | 658,000 | USD | 0000897101-22-000805 |
| FY 2020Yearly · 2020-06-30 | Product | Home Care | 29,323,000 | USD | 0000897101-21-000726 |
| FY 2020Yearly · 2020-06-30 | Product | Home Care Distributor | 430,000 | USD | 0000897101-21-000726 |
| FY 2020Yearly · 2020-06-30 | Product | Institutional | 2,000,000 | USD | 0000897101-21-000726 |
| FY 2020Yearly · 2020-06-30 | Product | International1 | 718,000 | USD | 0000897101-21-000726 |
| FY 2019Yearly · 2019-06-30 | Product | Home Care | 28,948,861 | USD | 0000897101-20-000703 |
| FY 2019Yearly · 2019-06-30 | Product | Institutional | 1,603,522 | USD | 0000897101-20-000703 |
| FY 2019Yearly · 2019-06-30 | Product | International1 | 747,367 | USD | 0000897101-20-000703 |
| FY 2018Yearly · 2018-06-30 | Product | Home Care | 26,255,579 | USD | 0000897101-19-000806 |
| FY 2018Yearly · 2018-06-30 | Product | Institutional | 1,550,820 | USD | 0000897101-19-000806 |
| FY 2018Yearly · 2018-06-30 | Product | International1 | 500,297 | USD | 0000897101-19-000806 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.